Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Veterinary medicine
Name of medicinal product: Avishield IB H120
Active substances:
Avian infectious bronchitis virus vaccine
Estonian, English, Latin
ATC code: QI01AD07
Dosage form: lyophilisate for oculonasal suspension/use in drinking water
Strength:  
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated May 8, 2023)
Package information leaflet (PIL): EST  (last updated May 8, 2023)
Labelling:  (last updated May 8, 2023)
Indication: For active immunisation of chickens in order to reduce the detrimental effect resulting from the infection by avian infectious bronchitis virus, serotype Massachusetts on the ciliary activity, which may be manifested in respiratory clinical signs. Onset of immunity: 3 weeks after vaccination Duration of immunity: 8 weeks after vaccination
Safety features: No
Marketing authorization holder: Genera d.d. 
Marketing authorization number: 2066 
Marketing authorization issued on: February 27, 2018 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Decentralised 
Assessment report:  (last updated February 27, 2018) 
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1730292  Avishield IB H120  lyophilisate for oculonasal suspension/use in drinking water  1000annus 10TK  Prescription           
1730304  Avishield IB H120  lyophilisate for oculonasal suspension/use in drinking water  2500annus 10TK  Prescription           
1730315  Avishield IB H120  lyophilisate for oculonasal suspension/use in drinking water  5000annus 10TK  Prescription           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere